Neurogenic Bladder Completed Phase 3 Trials for Alfuzosin (DB00346)

Also known as: Urinary Bladder Neurogenic / Neurogenic Urinary Bladder / Neurogenic Bladder Dysfunction / Bladder, Neurogenic / Urinary Bladder, Neurogenic / Neuropathic Bladder / Neurogenic dysfunction of the urinary bladder (finding) / Neurogenic bladder (finding) / (Cauda equina syndrome with cord bladder) or ([atonic] or [neurogenic] or [neuropathic] bladder) / Neurogenic bladder, not otherwise specified / Bladder neurogenic

IndicationStatusPhase
DBCOND0033269 (Neurogenic Bladder)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00576823Alfuzosin Treatment in Children and Adolescents With Hydronephrosis of Neuropathic EtiologyTreatment
NCT00629720Pharmacokinetics and Safety Study With Alfuzosin in Children and Adolescents With Elevated Detrusor Leak Point Pressure of Neuropathic EtiologyTreatment
NCT00549939Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder DysfunctionTreatment